tiprankstipranks
PremiumCompany AnnouncementsCG Oncology’s Financial Results and Clinical Developments
1M ago
CG Oncology reports Q3 EPS (30c), consensus (37c)
Premium
The Fly
CG Oncology reports Q3 EPS (30c), consensus (37c)
1M ago
CG Oncology announces publication in Nature Medicine of Phase 1b results
Premium
The Fly
CG Oncology announces publication in Nature Medicine of Phase 1b results
1M ago
CG Oncology initiated with an Outperform at RBC Capital
PremiumThe FlyCG Oncology initiated with an Outperform at RBC Capital
3M ago
J&J data presents ‘limited downside’ to CG Oncology, says Goldman Sachs
Premium
The Fly
J&J data presents ‘limited downside’ to CG Oncology, says Goldman Sachs
3M ago
CG Oncology initiated with a Buy at Roth MKM
Premium
The Fly
CG Oncology initiated with a Buy at Roth MKM
4M ago
CG Oncology initiates EAP for Cretostimogene Grenadenorepvec in U.S.
PremiumThe FlyCG Oncology initiates EAP for Cretostimogene Grenadenorepvec in U.S.
6M ago
CG Oncology upgraded to Buy from Neutral at Goldman Sachs
Premium
The Fly
CG Oncology upgraded to Buy from Neutral at Goldman Sachs
7M ago
CG Oncology expects cash runway through 2027
Premium
The Fly
CG Oncology expects cash runway through 2027
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100